Ioannou Y A, Bishop D F, Desnick R J
Division of Medical and Molecular Genetics, Mount Sinai School of Medicine, New York 10029.
J Cell Biol. 1992 Dec;119(5):1137-50. doi: 10.1083/jcb.119.5.1137.
Human lysosomal alpha-galactosidase A (alpha-Gal A) was stably overexpressed in CHO cells and its biosynthesis and targeting were investigated. Clone AGA5.3-1000Mx, which was the highest enzyme overexpressor, produced intracellular alpha-Gal A levels of 20,900 U/mg (approximately 100 micrograms of enzyme/10(7) cells) and secreted approximately 13,000 U (or 75 micrograms/10(7) cells) per day. Ultrastructural examination of these cells revealed numerous 0.25-1.5 microns crystalline structures in dilated trans-Golgi network (TGN) and in lysosomes which stained with immunogold particles using affinity-purified anti-human alpha-Gal A antibodies. Pulse-chase studies revealed that approximately 65% of the total enzyme synthesized was secreted, while endogenous CHO lysosomal enzymes were not, indicating that the alpha-Gal A secretion was specific. The recombinant intracellular and secreted enzyme forms were normally processed and phosphorylated; the secreted enzyme had mannose-6-phosphate moieties and bound the immobilized 215-kD mannose-6-phosphate receptor (M6PR). Thus, the overexpressed enzyme's selective secretion did not result from oversaturation of the M6PR-mediated pathway or abnormal binding to the M6PR. Of note, the secreted alpha-Gal A was sulfated and the percent of enzyme sulfation decreased with increasing amplification, presumably due to the inaccessibility of the enzyme's tyrosine residues for the sulfotransferase in the TGN. Overexpression of human lysosomal alpha-N-acetylgalactosaminidase and acid sphingomyelinase in CHO cell lines also resulted in their respective selective secretion. In vitro studies revealed that purified secreted alpha-Gal A was precipitated as a function of enzyme concentration and pH, with 30% of the soluble enzyme being precipitated when 10 mg/ml of enzyme was incubated at pH 5.0. Thus, it is hypothesized that these overexpressed lysosomal enzymes are normally modified until they reach the TGN where the more acidic environment of this compartment causes the formation of soluble and particulate enzyme aggregates. A significant proportion of these enzyme aggregates are unable to bind the M6PR and are selectively secreted via the constitutive secretory pathway, while endogenous lysosomal enzymes bind the M6PRs and are transported to lysosomes.
人溶酶体α - 半乳糖苷酶A(α - Gal A)在CHO细胞中稳定过表达,并对其生物合成和靶向作用进行了研究。克隆AGA5.3 - 1000Mx是酶表达量最高的克隆,其细胞内α - Gal A水平为20,900 U/mg(约100微克酶/10⁷个细胞),每天分泌约13,000 U(或75微克/10⁷个细胞)。对这些细胞的超微结构检查显示,在扩张的反式高尔基体网络(TGN)和溶酶体中有许多0.25 - 1.5微米的晶体结构,使用亲和纯化的抗人α - Gal A抗体进行免疫金颗粒染色后可见。脉冲追踪研究表明,合成的总酶中约65%被分泌,而内源性CHO溶酶体酶则不分泌,这表明α - Gal A的分泌具有特异性。重组的细胞内和分泌型酶形式正常加工并磷酸化;分泌型酶具有甘露糖 - 6 - 磷酸基团,并与固定化的215 - kD甘露糖 - 6 - 磷酸受体(M6PR)结合。因此,过表达酶的选择性分泌并非由于M6PR介导途径的过饱和或与M6PR的异常结合。值得注意的是,分泌的α - Gal A被硫酸化,并且随着扩增倍数增加,酶硫酸化的百分比降低,推测是由于TGN中硫酸转移酶无法接近酶的酪氨酸残基。人溶酶体α - N - 乙酰半乳糖胺酶和酸性鞘磷脂酶在CHO细胞系中的过表达也导致了它们各自的选择性分泌。体外研究表明,纯化的分泌型α - Gal A会根据酶浓度和pH沉淀,当10 mg/ml的酶在pH 5.0下孵育时,30%的可溶性酶会沉淀。因此,推测这些过表达的溶酶体酶在到达TGN之前通常会被修饰,而TGN中更酸性的环境会导致可溶性和颗粒性酶聚集体的形成。这些酶聚集体中有很大一部分无法结合M6PR,并通过组成型分泌途径被选择性分泌,而内源性溶酶体酶则结合M6PR并被转运到溶酶体中。